INTRODUCTION
Polycomb repressive complex 2 (PRC2)-mediated trimethylation of H3K27 is associated with transcriptional silencing (Margueron and Reinberg, 2011) . Mammalian PRC2 contains the enzyme EZH1 or EZH2 and two proteins-EED and SUZ12-that are required to assemble the active complex (Kuzmichev et al., 2002; Pasini et al., 2004) . Mouse embryos lacking PRC2 die soon after gastrulation (Faust et al., 1998; Pasini et al., 2004) , and much of the current understanding of mammalian PRC2 activity rests on studies in embryonic stem cells (ESCs). However, ESCs and early embryos have unique, globally permissive chromatin (Meshorer et al., 2006; Zhu et al., 2013) , and their regulatory processes may differ from those in adult tissues.
In PRC2-deficient ESCs, some genes ordinarily restricted to specific tissues may activate prematurely (Boyer et al., 2006; Pasini et al., 2007) . Promoters of these genes are commonly ''bivalent,'' meaning that they carry the activation-associated histone mark H3K4me3 in addition to H3K27me3 and lose one or the other mark as ESCs differentiate (Azuara et al., 2006; Bernstein et al., 2006; Mikkelsen et al., 2007) . H3K27me3 domains also appear or expand in differentiated cells concomitant with gene silencing (Hawkins et al., 2010) , which suggests that PRC2-mediated repression, established during development, controls spatiotemporal gene activity. However, promoter bivalency and its functional significance are not readily evident in fetal or adult somatic cells (Alder et al., 2010; Cui et al., 2009; Lien et al., 2011; Mohn et al., 2008) and may be confined to early mammalian embryos (Voigt et al., 2013) . Moreover, ESCs cultured in the presence of serum differ from those maintained in a ''ground state'' by the inhibition of MEK and GSK3 kinases (Ying et al., 2008) , and only 31% of genes showing bivalency in the presence of serum do so under these ''2i conditions,'' where H3K27me3 levels are significantly lower at many genes (Marks et al., 2012) . Moreover, genes are minimally perturbed in ESCs cultured in 2i medium, where PRC2 seems to maintain-rather than initiate-repression of some genes, and blockade of transcription recruits H3K27me3 at other genes, implying that the mark may reflect-and not cause-their repression (Riising et al., 2014) . Thus, although PRC2-mediated H3K27me3 is widely regarded as a universal restraint on gene transcription, its functions and requirements in vivo remain uncertain and may be confined to selected genes.
PRC2 deficiency in individual mouse tissues causes specific and limited defects. Impaired progenitor cell replication in PRC2 null blood, skin, and other tissues is attributed to the activation of genes that inhibit the cell cycle, such as Cdkn2a, because concomitant loss of single Cdkn genes rescues the overt defect (Delgado-Olguín et al., 2012; Ezhkova et al., 2011; Hidalgo et al., 2012; Juan et al., 2011; Xie et al., 2014) . Strikingly few other genes-and different genes in different tissues-are deregulated. Because transcriptional aberration in mutant cells has not been evaluated systematically with respect to basal tissue-specific histone marks, the basis for the limited and diverse outcomes is unclear, and PRC2 function in adult somatic tissues lacks a cogent unifying model. To derive such a model, we assessed PRC2 function in the epithelium of the adult mouse intestine, where cycling Lgr5 + intestinal crypt stem cells (ISCs) and transit-amplifying cells support the continual turnover of terminally differentiated villus cells (Barker et al., 2007) . We found that about 2,000 genes have constitutively heavy H3K27me3 marks in both crypt and villus cells, similar to the numbers strongly marked in mouse blood and skin. At least half of these genes, in each case, lack H3K27me3 in one or both of the other tissues, and their promoters carry different levels of H3K4me3 and H3K4me2; most of these genes are not identified as bivalent in ESCs grown in serum or under 2i conditions. Promoter bivalency in the adult intestine does not position genes for expression in differentiated villus cells. Rather, H3K27me3 is necessary to maintain their constitutive silence, as genes with acquired tissue-specific bivalency are virtually the only targets of PRC2-dependent repression in the intestine, skin, and blood. Aberrant gene activation in each case is proportional to the levels of promoter H3K4me2/3 marks. Thus, hundreds of genes in each adult tissue carry concomitant H3K4me2/3 and H3K27me3, and PRC2 is required in adult cells specifically to preclude expression of these genes.
RESULTS

A Limited Role for H3K27me3 Dynamics in Intestinal Crypt-Villus Differentiation
In the adult mouse intestinal epithelium, H3K27me3 is especially abundant in villus cells; EZH2 levels are highest in the crypts, where it is present in all replicating cells, including Lgr5+ ISCs at the crypt base and transit-amplifying cells in higher tiers ( Figure S1A ). Chromatin immunoprecipitation sequencing (ChIP-seq) for H3K27me3 on pure populations of villus cells and Lgr5 + ISCs gave robust, reproducible data (Figures S1B and S1C). Peaks called by SICER ) gave the expected distribution in promoters, gene bodies, and intergenic regions ( Figure S1B ), with average peak width $6.5 kb. The range of H3K27me3 levels was wide: in unsupervised k-means clustering (k = 5), two groups of genes showed exceptionally high H3K27me3, with marks present at the promoters and bodies of 551 genes in cluster 1 and mainly at the promoters of 1,777 genes in cluster 2 ( Figure S1D ). Most marked genes identified by SICER fell in clusters 1 or 2 and were shared among duplicate (ISC) or triplicate (villus) samples ( Figure S1D ). Promoters in clusters 3 and 4 carried, on average, at least 3-fold less H3K27me3 than those in clusters 1 and 2 ( Figure S1E ), whereas cluster 5 showed almost no H3K27me3, either in this analysis or by ChIP-seq peak calling. H3K27me3 profiles were remarkably similar in ISCs and villus cells ( Figure S1B ), even at heavily marked genes, and RNA sequencing (RNA-seq) analysis of the same cell populations indicated that most genes in clusters 1 and 2 are silent in both compartments ( Figure 1A ). Because these profiles could conceal a subtle dynamic relationship of H3K27me3 to changes in mRNA, we used DiffReps (Shen et al., 2013) to identify 864 genes with different H3K27me3 levels (q < 0.001) anywhere in the gene, including promoters, and CuffDiff (Trapnell et al., 2012) to identify $4,000 genes with different transcript levels (R3-fold, q < 0.05) in ISCs and villus cells. Most differences in H3K27me3 were low in magnitude and/or confidence and occurred at genes that did not change in expression ( Figure 1B ). Only 109 of 1,932 genes (5.6%) that were activated in villus cells-e.g., Cdkn2b (Figure 1C) -showed significantly less marking than in ISCs. Three independent ChIP-seq experiments ( Figure S1C ) did not reveal H3K27me3 loss at hundreds of other genes that were activated as strongly in villus cells but showed reproducible and modest changes at genes that are equally active in ISCs and villus cells ( Figures 1B-1D) . Therefore, the poor association between H3K27me3 loss and mRNA gain does not reflect assay insensitivity. Rather, most genes activated in villus cells lack H3K27me3 in either cell type ( Figure 1D ).
Conversely, 248 of the 637 genes (39%) that showed significantly more H3K27me3 in villus cells than in ISCs-including Lgr5, Ascl2, and Myc-are highly active in ISCs and repressed in villus cells ( Figure 1E ). Together, these findings imply that PRC2 has little role in restraining villus genes in ISCs but may mediate silencing of genes such as Lgr5 and Ascl2 once ISCs begin to differentiate. The highly similar H3K27me3 profiles in ISCs and villus cells raise the additional possibility of a larger role in tissue-specific gene control than in regulating genes within a tissue.
Tissue-Restricted Patterns of H3K27me3 and Bivalent Promoters in Adult Somatic Cells
To compare the distribution of H3K27me3 marks in the intestine with that in other mouse tissues, we applied the same unsupervised k-means clustering as described earlier ( Figure S1D ) to public ChIP-seq data from self-renewing cells that originate in distinct germ layers: matrix cells in the skin and lineage-marker-depleted Sca1 + Kit + (LSK) cells in blood (Hasemann et al., 2014) . About 2,000 genes were heavily marked in each case ( Figure S2A) , and a total of 3,578 genes belonged in the top two clusters in the intestine, skin, or blood. Only 976 of these genes were heavily marked and transcriptionally inactive in all three tissues, constituting a group that is particularly enriched for early developmental functions ( Figure S2B ) and which we designate as group 1 (denoted by a dotted brown bar in Figure 2A) . A larger fraction of genes (group 2) was robustly marked in just one or two tissues and largely devoid of H3K27me3 in the other(s). For example, 743 genes were uniquely marked in intestinal cells; RNA levels in each case were negatively correlated with high H3K27me3 (Figure 2A) . Although H3K4me2/3 has previously been noted at H3K27me3-bearing promoters in some fetal, adult, and ESCderived cells (Abraham et al., 2013; Barski et al., 2007; Liu et al., 2013; Mikkelsen et al., 2007) , the distribution and functions of bivalency have not been established. Notably, the genes we identify as heavily marked with H3K27me3 in the three adult tissues showed distinct patterns of promoter H3K4me3 marking ( Figure 2A ). Genes in group 1 carried little to no H3K4me3 in any tissue. Those in the second group, which were marked with H3K27me3 in just one or two tissues, showed high average H3K4me3 and mRNA levels in the others. In Figure 2A , a solid brown bar denotes genes that carry H3K27me3 in intestinalbut not in blood and/or skin-cells (group 2a), and the blue bar denotes genes marked with H3K27me3 in blood and/or skin-but not in intestinal-cells (group 2b). Whereas H3K27me3 levels were comparably high at promoters in groups 1 and 2, levels of H3K4me3 varied widely and were, on average, considerably higher in group 2, even in the index tissue with high H3K27me3 (shown for the intestine in Figure 2B ). For example, Barx1, a silent gene from group 1, has high H3K27me3 and virtually no H3K4me3 at the promoter in villus cells, whereas Sox9, an expressed gene from group 2b, lacks H3K27me3 in intestinal cells but has considerable H3K4me3 ( Figure 2C ). Genes from group 2a, such as Tlr2, are distinct in showing significant trimethylation at H3K27 and H3K4. This is the defining feature of promoter bivalency in ESCs (Bernstein et al., 2006) , where these nominally opposing marks appear on the same nucleosome in the same cells (Bernstein et al., 2006; Voigt et al., 2012) . Unlike H3K4me3 levels at bivalent genes in ESCs, which are uniformly high (Bernstein et al., 2006) , the levels in adult intestinal cells ranged from 30 density units-similar to expressed genes-to weak signals that eluded detection by peak calling; similar variation was evident in blood and skin cells (Figure 2A) . Genes with heavy H3K27me3 are tightly repressed, regardless of whether the promoter carries H3K4me3, as Figure 2D shows for intestinal stem and villus cells. Thus, bivalent domains in the adult intestine do not poise genes for expression in differentiated cells.
To verify that H3K27me3 marking and bivalency are consistent across stages in crypt-villus differentiation, we examined two intermediate transit-amplifying populations: crypt enterocyte and secretory progenitors (Kim et al., 2014) . To detect modified histones at the resolution of single nucleosomes, we digested chromatin with micrococcal nuclease and, in lieu of H3K4me3, we performed ChIP-seq for H3K4me2, a mark known to be highly correlated with H3K4me3 at promoters (Barski et al., 2007; Heintzman et al., 2007; Mohn et al., 2008) , as we confirmed ( Figure S2C ). Genes in groups 1 and 2a, as defined in ISCs and villus cells, showed the strongest H3K27me3 signals in both types of crypt progenitors, and H3K4me2 was clearly present at group 2a promoters ( Figure 3A) . Moreover, H3K4me2 levels varied exactly as they did in ISCs and villus cells, with the average signal in group 2a intermediate between those in groups 1 and 2b ( Figure S3A) . Thus, silent genes with promoter H3K4me2/3 carry tissue-restricted H3K27me3 marks that are stable in four distinct intestinal cell populations.
Bivalent Promoters in Adult Tissues Differ from Those in ESCs
To determine whether H3K27me3-marked genes and bivalent domains in adult tissues are also targets of PRC2 regulation in early embryos, we used unsupervised k-means clustering, as described earlier (k = 5), to identify genes heavily marked in undifferentiated ESCs grown in the presence of serum (Subramanian et al., 2013) . The 2,159 genes in clusters 1 and 2 correspond to most of the genes at which SICER identified peaks ( Fig 
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Figure 2. Differential Bivalent Domains in Adult Mouse Tissues
(A) H3K27me3 (amber), mRNA (green), and promoter H3K4me3 (blue) profiles in adult intestinal villus, blood (Hasemann et al., 2014) , and skin cells. Genes strongly marked in any of the three tissue types were collated (Figures S2A and S2B) and clustered on the basis of H3K27me3 levels in one or more tissues. H3K27me3 is represented on gene bodies (five equal-sized bins) ± 2 kb, and H3K4me3 is represented ± 1.5 kb from the TSS (center). (27.8%) in at least one tissue ( Figures  S3C and S3D ), revealing broad erasure of some H3K27me3 marks and tissueselective erasure of others during development. About half the marked ESC promoters remained so in at least one adult, but these genes were not evenly distributed. Among genes in group 1 (i.e., those marked and silent in all three adult tissues), 82% have high H3K27me3 in ESCs. In contrast, 77% of genes marked only in the adult intestine, and 48% of genes marked in the intestine and one other tissue, lack H3K27me3 in ESCs ( Figures 3B and 3C ).
To verify this late acquisition of H3K27me3 in adult tissues, we pooled all putative PRC2 targets identified in various ChIP-seq analyses of H3K27me3 (Das et al., 2014; Shpargel et al., 2014; Subramanian et al., 2013) or SUZ12 (Riising et al., 2014) in undifferentiated ESCs grown in serum or 2i conditions. Even this liberal set of 8,173 candidate target genes in ESCs excluded at least 751 of the 3,578 genes (21%) that carry H3K27me3 selectively in adult tissues ( Figure S3E ). The canonical definition of bivalency in ESCs (Li et al, 2013 ) also applies to only 44% of genes showing high H3K27me3 in the adult intestine ( Figure 3D) . Moreover, the functions of genes with shared and tissue-restricted bivalency differ markedly: transcription factors that regionalize and pattern the embryo predominate among PRC2 targets in ESCs, whereas genes marked mainly in adult tissues serve diverse functions, such as organogenesis and cytoskeletal organization (intestine), receptor tyrosine kinase signaling (blood), and excretion (skin) ( Figure S4 ). Thus, hundreds of genes in various somatic tissues acquire bivalent domains some time after early embryogenesis.
PRC2 Loss In Vivo Impairs Cell Proliferation and Preferentially Activates Genes with Acquired TissueRestricted H3K27me3
To define this dependency, we disrupted Eed, a gene required for PRC2 assembly and catalytic activity (Montgomery et al., 2005) . Crosses between Eed Fl/Fl (Xie et al., 2014) H3K27me3 first became restricted to villus tips, i.e., to cells born before Eed deletion, and total loss ensued within 4 days (Figure 4A ; Figure S5A ). This loss reflected the absence of EZH2 ( Figure S5B ), indicating that enzymes in the PRC2 complex are unstable in the absence of EED. MKI67 staining and bromodeoxyuridine (BrdU) incorporation revealed markedly reduced crypt cell replication (Figures 4B and S5C) , and villi were consequently stunted and dysmorphic ( Figures 4C and S5A ). In the wake of widespread crypt failure, a few crypts began to fill with replicating cells ( Figures 4B and 4C , arrowheads), increased gradually in abundance, and produced normal villi alongside stunted Eed null villi. The presence of EZH2 and H3K27me3 in these intact villi (Figures 4A and S5B, arrowheads) indicates that they originate in cells that escaped biallelic Eed deletion; the selective advantage of such wild-type crypts over mutant crypts is well established in other mouse models (Bettess et al., 2005; van der Flier et al., 2009) . Alkaline phosphatase activity, a marker of cell maturity, was confined to the tips of Eed À/À villi, revealing delayed or aberrant-not precocious-enterocyte maturation ( Figure 4D ). mRNA sequencing (mRNA-seq) analysis revealed that transcripts expressed (reads per kilobase per million [RPKM] sequence tags > 1) in wild-type villus epithelium-including abundant transcripts such as Alpi and Villin-were largely undisturbed in Eed À/À intestinal villus cells ( Figure 5A ). Indeed, considering all dysregulated genes (q < 0.05), those expressed in Eed +/+ villi changed by barely 2-to 3-fold, with RNA gains and losses occurring in roughly equal proportion ( Figures 5A and 5B) . wild-type cells, and, when occasionally present, the levels are low ( Figure 5B ). Therefore, these minor disturbances likely reflect indirect or secondary effects of PRC loss. Furthermore, only 20 of the 248 ISC-specific genes that gain H3K27me3 upon silencing in wild-type villus cells ( Figure 1E ) showed elevated expression in Eed À/À villi ( Figure S5D ), indicating that PRC2 is not required to repress most of these genes. Rather, PRC2 loss prominently affected genes that are silent (RPKM < 1) and carry heavy H3K27me3 marks in the wild-type intestine ( Figure 5B) ; activation of these genes in Eed À/À villi indicates that they are the principal, direct targets of PRC2 repression in vivo. They include Cdkn2a (RPKM gain, 142.86), a known PRC2 target that singularly explains replication arrest in other PRC2 null tissues (Ezhkova et al., 2011; Hidalgo et al., 2012; Xie et al., 2014) , and, hence, likely also in intestinal crypts; the linked gene Cdkn2b, which is dynamically marked and regulated in the wild-type epithelium ( Figures  1B and 1C) , was unperturbed ( Figure S5E ). Notably, Cdkn2a was one of only two genes aberrantly activated >3-fold in each of the three adult tissues we considered (Tbx15 was the other), and different genes were prominently derepressed in PRC2 null skin or blood ( Figure 5C, top) . Moreover, the average mRNA gain in Eed À/À villi was significantly higher for genes that carry H3K27me3 only in the intestine than for genes marked in all tissues ( Figure 5D ). Thus, the principal targets of PRC2 are not the few genes that acquire H3K27me3 during intestinal crypt-villus differentiation, or the large number that is constitutively marked in multiple tissues, but genes with intestine-restricted H3K27me3. Genes selectively reactivated in blood or skin also were those bearing high tissue-specific H3K27me3 in each case ( Figure 5C , bottom). See also Figure S5 . regulated genes (direct targets, very few of which showed reduced expression) marked with H3K27me3 in all wild-type tissues or only in the intestine. Boxes represent the 25th and 75th percentiles, and whiskers represent the 1.53 interquartile range. Significance in (B) and (D) was determined using the Mann-Whitney test.
Activation-Associated H3K4me2/3 at Promoters Underlies Gene Responses to PRC2 Loss Genes carrying equally strong H3K27me3 marks in wild-type intestines were activated to different degrees in Eed À/À villi, where mRNA gains ranged from <1 RPKM (e.g., Zic2; gain, 0.37) to dozens (e.g., Phld3a; gain, 48.4) ( Figure 5A ). This variation was not spurious, because even tiny increases (e.g., Emx2; gain, 0.22 RPKM) were highly similar across triplicate samples that showed high overall concordance ( Figure 6A ; Figure S6 ). Among genes strongly marked with H3K27me3 in wild-type intestines, average mRNA levels for genes located within 100 kb of highly deregulated genes were similar to those that remained silent ( Figure S7A ). Moreover, although all four Hox clusters are broadly and strongly marked with H3K27me3 in adult wild-type tissues, different tissues activate distinct Hox genes, and genes in the same Hox cluster showed striking differences in mRNA expression in the mutant intestine ( Figure S7B ). Thus, proximity to active genes did not overtly influence PRC2 dependency in vivo. Instead, the extent of aberrant gene activity was commensurate with the levels of H3K4me2 and H3K4me3 at the promoter in wild-type intestinal villi ( Figure 6B ). Genes such as Nkx6.1, with high H3K4me2/3, were substantially derepressed; genes such as Aqp6, lacking promoter H3K4me2/3, remained silent; and genes such as Nr2f1, with intermediate H3K4me2/3 marking, were activated modestly ( Figure 6C ). To confirm that mRNA increases in PRC2 null cells are a function of H3K4me3 marking in wild-type cells, we divided all the genes aberrantly activated in mutant villus cells into quintiles of the absolute gain in mRNA levels. Average promoter H3K4me3 signals were proportional to these quintiles of mRNA gain, whereas H3K27me3 levels were identical in all quintiles (Figure 7A) . Activation of H3K27me3-marked genes in PRC2 null blood and skin cells (Ezhkova et al., 2011; Xie et al., 2014 ) also mirrored promoter H3K4me3 levels in the respective wildtype tissues ( Figures 7B and S7C) . Conversely, we arranged all genes heavily marked with H3K27me3 in the intestine (clusters 1 and 2 in Figure S1D) , according to the level of promoter (transcriptional start site [TSS] ± 0.5 kb) H3K4me3 in wild-type intestines ( Figure 7C ). As expected, genes in group 1, which lack H3K4me3 in any tissue (Figure 2A ), sorted to the left and genes in group 2a, which show variable promoter H3K4me3 marks in the wild-type intestine, sorted to the right. Genes aberrantly activated in Eed À/À intestinal villi mapped mainly to the latter group and transcript levels were directly proportional to native H3K4me3 marking in wild-type cells ( Figures 7C and S7D ). These data reveal that transcriptional consequences of PRC2 loss in adult somatic cells in vivo are virtually confined to genes with acquired tissue-specific bivalency and directly reflect native promoter H3K4me2/3 levels. Of note, ChIP-seq showed Pol2 occupancy at transcribed genes that lack H3K27me3 (group 2b) but not at H3K27me3-marked genes, regardless of the absence (group 1) or presence (group 2a) of H3K4me3 ( Figures 7D and  7E) . Thus, H3K27me3 may preclude transcription of tissuerestricted bivalent genes in part by preventing Pol2 recruitment.
DISCUSSION
Findings in ESCs are commonly extended to implicate H3K27me3 as a transcriptional repressor in other contexts. Even in ESCs, however, PRC2 seems dispensable in initiating gene silencing, and H3K27me3 appears at many genes that are repressed in response to other factors (Riising et al., 2014) . Moreover, poising of promoters for activation in differentiating cells may be a phenomenon unique to ESCs under specific conditions, and bivalent domains lack a proven role in adult tissues . Indeed, it has remained unclear whether H3K27me3 and other histone marks are necessary to silence genes or merely signify the lack of transcriptional activity. Our study clarifies PRC2's role and target genes in adult somatic tissues.
Bivalent Domains in the Adult Intestinal Epithelium Are Distinct from Those in ESCs
Several features distinguish the bivalent promoters we identify in adult cells from those previously described in undifferentiated into quintiles of absolute increase in mRNA levels.
(B) Average H3K4me3 profiles for the top, middle, and bottom quintiles of genes activated in PRC2 null blood (Xie et al., 2014) and skin (Ezhkova et al., 2011) , determined from published microarray data. Heatmaps are shown in Figure S7 . (C) Gene deregulation in PRC2 null villus epithelial cells (absolute mRNA gain, y axis) is highly correlated with the level of promoter H3K4me3 in wildtype intestine (x axis). Genes in group 1 carry little to no H3K4me3 and accordingly concentrate toward the left (violin plots); few such genes (examples named) are activated. In contrast, genes in group 2a express in nearly linear relation to basal H3K4me3 levels. The dotted line shows curve fit using non-linear regression. Figure S7D shows the same analysis restricted to transcripts increased at p < 0.05. ESCs. First, more than half of the 1,322 bivalent genes in the small intestineand similar fractions in skin and bloodlack significant H3K27me3 in at least one other adult tissue; different genes carry bivalent marks in different organs; and only 23% of genes marked with H3K27me3 exclusively in the intestine are also marked in ESCs. Thus, bivalency acquired during development is extensive and tissue restricted. Second, promoter bivalency is largely invariant in ISCs, crypt progenitors, and terminally mature villus cells, and loss of PRC2 does not cause precocious gene activity or accelerate enterocyte differentiation. Thus, promoter bivalency is not a progenitor-cell attribute that poises genes for expression in differentiated cells but rather a feature that distinguishes tissues from each other. Third, whereas H3K4me3 and H3K27me3 levels are equally high at bivalent promoters in ESCs (Bernstein et al., 2006) , H3K4me2/3 signals in adult cells vary widely in the face of uniformly high H3K27me3, and gene activity in the absence of PRC2 is highly correlated with the basal level of H3K4me2/3. We conclude that the latter marks-or some feature associated with them-make genes vulnerable to transcription and that PRC2 suppresses this latent tendency. Fourth, Pol2 is present at bivalent promoters in ESCs (Marks et al., 2012) but not at those in intestinal villus cells. Finally, tissue-specific bivalent genes in at least three adult tissues derived from different germ layers make up the vast majority of genes that depend on PRC2 for tight repression. Genes with strong H3K27me3 marks in all three tissues (group 1) typically lack concomitant H3K4me2/3, and, even in this group, the few genes with barely detectable H3K4me2/3 are weakly reactivated in Eed À/À intestines, commensurate with low H3K4me2/ 3. Only a handful of genes-including certain Hox genes-are reactivated, despite low levels of H3K4me2/3 marking in wildtype cells.
Intestine-restricted bivalency arises some time after the ESC stage, at genes that serve in tissue morphogenesis, organelle biogenesis, and cytoskeletal organization ( Figure S4 ). Bivalent marks specific to the skin and blood also appear at genes with plausible roles in the development of those tissues. Therefore, these genes were likely active during organogenesis, and some persistent transcription factor or chromatin modification might leave them susceptible to transcription in adults. We propose that tissue-specific control mechanisms recruit PRC2 to place H3K27me3 at these genes in order to avoid mRNA expression that is dispensable and possibly deleterious. It is worth noting in this light that, although deletion of Cdkn2a restores the proliferative potential of PRC2-deficient blood cells (Hidalgo et al., 2012) , other defects remain, leading to stem-cell exhaustion, for example (Xie et al., 2014) . Thus, Cdkn2a is not the only target of PRC2 repression in adult tissues, and PRC2-dependent silencing functions include preventing transcription of selected developmental genes in adult cells. Regardless of whether target promoters carry H3K4me2/3 fortuitously or as vestiges of tissues' particular ontogeny, our findings argue that the two opposing marks lie in the same cells, not in different subpopulations.
As it is unclear exactly when, in development, genes acquire bivalency, it is difficult to study how PRC2 may be recruited at bivalent genes. Unmethylated CpG islands (CGIs) are thought to be an important means of PRC2 recruitment (Mohn et al., 2008; Riising et al., 2014; Voigt et al., 2013) and could have a role at ISC-specific genes, such as Lgr5, that acquire H3K27me3 during crypt differentiation. At these 248 genes, only 186 of the 489 sites (38%) that gain H3K27me3 lie in CGIs, corresponding to 155 genes (62%). Thus, PRC2 can be recruited to some sites independent of CGIs or spreads H3K27me3 into these sites from distant CGIs.
PRC2 Requirements in Adult Somatic Tissues
This study helps distinguish PRC2 requirements from its incidental activities in adult tissues in vivo. Although most intestinal genes heavily marked with H3K27me3 are constitutively silent, thousands of other silent genes carry little to no H3K27me3. Furthermore, genes dynamically regulated during crypt-villus differentiation generally lack reciprocal changes in H3K27me3 and are unaffected by PRC2 loss; even most of the 248 genes that get silenced and simultaneously acquire H3K27me3 in wild-type villus cells do not depend on PRC2 for this silencing. Thus, H3K27me3 is not an obligate repressive mark during intestinal self-renewal and behaves, at many genes, as a marker, rather than a cause, of transcriptional inactivity. Even among genes that carry H3K27me3 in multiple adult tissues (group 1), few become active in the absence of PRC2, at least in adults in the time frame of our experiments. It is unclear why these genes remain silent. The absence of promoter H3K4me3 may be sufficient to avoid activation, or other repressive effectors, such as methylated DNA, may prevail in the absence of H3K27me3. PRC2 is, however, required to repress genes with tissuerestricted bivalency, and our findings imply that H3K27me3 actively opposes some feature, such as recruitment of Pol2, that might predispose those genes to transcriptional activity.
Drugs that inhibit the PRC2 complex are currently being developed to treat certain cancers. Our findings in vivo offer a platform to anticipate drug toxicities and to design pharmacodynamic markers. Because crypt cell replication is as vulnerable to PRC2 loss as other self-renewing tissues (Delgado-Olguín et al., 2012; Ezhkova et al., 2011; Schwarz et al., 2014; Xie et al., 2014) , EZH2 inhibitors may induce intestinal toxicity. Moreover, different genes have bivalent promoters in various tissues, and repression of genes with high native H3K4me2/3 in wild-type cells is especially dependent on PRC2. mRNA expressed from such genes in readily accessible cells, such as adult leukocytes or the oral mucosa, may serve as a useful gauge of drug activity.
EXPERIMENTAL PROCEDURES Mice
Lgr5
EGFPÀIRESÀCreER (Barker et al., 2007) and wild-type C57BL/6 mice were purchased from The Jackson Laboratory; Villin CreERÀT2 mice (el Marjou et al., 2004 ) were a gift from Sylvie Robine (Institut Pasteur); Eed Fl mice were described previously (Xie et al., 2014) . Mice 8 weeks or older received 2 mg tamoxifen by intraperitoneal injections for 5 consecutive days and, in some studies, 1 mg BrdU 60 min before euthanasia. RNA was collected from the proximal one-third small intestine (duodenum) 4 days after the end of tamoxifen treatment. Animals were housed under specific pathogen-free conditions and handled according to protocols approved by the Dana-Farber Cancer Institute's Animal Care and Use Committee.
Cell Isolation
Mouse duodeni were washed in PBS and rotated in 5 mM EDTA in PBS (pH 8) at 4 C for 40 min, with manual shaking every 10 min. Suspensions were passed through 70-mm filters (BD Falcon). Villus epithelium retained on the filters was washed in PBS before extraction of RNA or chromatin.
Lgr5
EGFPÀIRESÀCreER mouse intestines were depleted of villi by scraping with glass slides. Duodenal fragments were rotated in 5 mM EDTA in PBS (pH 8) at 4 C, with manual shaking every 10 min for 40 min and a change of EDTA solution after 30 min. Isolated crypt epithelium was disaggregated over 30 min in 4% TrypLE solution (Invitrogen) at 37 C, and GFP hi cells were isolated by flow cytometry (BD FACSAria II SORP), as described previously (Kim et al., 2014) . Isolation of crypt progenitors is described in the Supplemental Experimental Procedures.
ChIP-Seq and Data Analysis $3 3 10 6 GFP hi mouse ISCs and $5 3 10 6 wild-type crypt progenitors or villus epithelial cells were used for ChIP-seq analysis of H3K27me3 and H3K4me3, and data were normalized, as described in the Supplemental Experimental
Procedures. H3K27me3-enriched regions were identified by SICER version 1.1 ), using 200-bp sliding windows, a gap size of 600 bp, input material for background subtraction, and a false discovery rate (FDR) of 0.01. Regions (broad peaks) were assigned to genes if they overlapped anywhere from 2 kb upstream of the TSS to 2 kb downstream of the transcriptional end site (TES), thus identifying 6,719 marked genes in villus cells and 6,428 marked genes in ISCs. Nucleosomes carrying H3K4me3 or H3K27me3 in crypt progenitors and H3K4me3 in adult villi were determined with nucleosome positioning from sequencing (NPS) (Zhang et al., 2008) , using default parameters. Differential ChIP signals were identified using DiffReps version 1.55.4 (Shen et al., 2013) and using H3K27me3-ChIP and ChIP-Input (background) with default parameters, FDR < 0.001 as a cutoff, and negative binomial test for statistical analysis. To calculate H3K27me3 density, genes were fitted to a length of 10 kb, divided in five equal bins. Scores were used to group genes by unsupervised k-means clustering in the DeepTools package (Ramírez et al., 2014) and plotted as heatmaps, representing each gene in seven bins (À2 kb, five bins from TSS to TES, and +2 kb). Violin plots of H3K27me3 signal density and genes in group 1 or group 2a (Figures 5C and 7C) were generated using ggplot2 tools in R (http://ggplot2.org). H3K4me2/3 and H3K27me3 densities were determined over 1.5 kb in both directions from TSSs using 10-bp windows and plotted as TSS-centered heatmaps. H3K4me3 read counts over the TSS ± 0.5 kb were used to determine the relation of wild-type H3K4me3 signals to gene activation in Eed À/À intestinal villi ( Figure 7C ). Aggregate read density profiles of H3K27me3, H3K4me3, and Plo2 were generated using SitePro (Liu et al., 2011) and ggplot2 tools in the R package. Venn diagrams were created using BioVenn (Hulsen et al., 2008) .
mRNA-Seq
Total RNA was extracted using TRIzol (Life Technologies), and 1 mg was used to prepare libraries with TruSeq RNA Sample Preparation Kit V2 (Illumina RS-122-2001) . Single-end sequences obtained on Illumina HiSeq 2000 (50-bp reads) or NextSeq 500 (75-bp reads) instruments were aligned to the mouse genome (Mm9, NCBI Build 37) using TopHat version 2.0.6. Library information appears in Table S1 . mRNA levels of genes in triplicate samples were calculated as RPKM using Cufflinks version 2.0.2 (Trapnell et al., 2012) . We determined differential gene expression using CuffDiff version 2.2.1 with an FDR threshold of 0.05 and generated heatmaps using GENE-E (Broad Institute).
Re-analysis of Published Data
ChIP-and RNA-seq datasets that we used from skin (matrix cells), blood (LSK cells), and undifferentiated ESCs are listed in the Supplemental Experimental Procedures. Raw data (FASTQ or BAM files) were processed similarly to our data from intestinal cells and re-aligned to the mouse genome (Mm9, NCBI Build 37), and H3K27me3-marked regions were identified using SICER. Genes in each tissue were grouped by k-means clustering (k = 5) using DeepTools, and the two clusters with highest H3K27me3 were considered for tissue-specific gains and losses. To avoid bias from different conditions and sources of data, comparisons of H3K27me3 ( Figure 5C ) and H3K4me3 (Figures 7A and 7B) marking were conducted separately on genes within each tissue. Gene expression in PRC2-deficient skin and blood cells (Ezhkova et al., 2011; Xie et al., 2014) had been determined on Affymetrix Mouse Genome 430 2.0 arrays. Given the lower transcript coverage ($13,000 genes) and lower sensitivity to detect differences, compared to RNA-seq, Figure 5C only considers genes that are represented on these arrays, marked by H3K27me3 in the native tissue, and altered >3-fold in the absence of PRC2 activity.
ACCESSION NUMBERS
The accession number for the data (Table S1 ) reported in this paper is GEO: GSE71713. 
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